Kenvue Inc. (KVUE)
NYQ – Real vaqt narxi. Valyuta: USD
17.47
+0.30 (1.75%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Find any stock by ticker or company name

NYQ – Real vaqt narxi. Valyuta: USD
17.47
+0.30 (1.75%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Kenvue Inc. Qo'shma Shtatlar, Shimoliy Amerikaning qolgan qismi, Yevropa, Yaqin Sharq, Afrika, Osiyo-Tinch okeani va Lotin Amerikasida iste'molchilar salomatligi kompaniyasi sifatida faoliyat yuritadi. U uchta segmentda faoliyat yuritadi: O'z-o'zini parvarish qilish, Teri salomatligi va go'zallik hamda Asosiy salomatlik. Kompaniya tomoq, shamollash va allergiya, og'riqni davolash, ovqat hazm qilish salomatligi, chekishni tashlash va ko'z uchun dori-darmonlarni, shuningdek, boshqa tabiiy ilhomlantirilgan va o'z-o'zini parvarish qilish mahsulotlarini, raqamli diagnostika va telemeditsinani; yuz va tana parvarishi, soch, quyosh va boshqa parvarish mahsulotlarini; og'iz va bola parvarishi, ayollar salomatligi, yaralar parvarishi va boshqa asosiy salomatlik mahsulotlarini; tamponlarni; kosmetik vositalarni; hamda vitaminlar va qo'shimchalarni taklif etadi. U o'z mahsulotlarini Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee’s Naturals va Zyrtec brendlari ostida sotadi; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX va Rogaine; BAND-AID, Carefree, Desitin, Johnson’s, Listerine, o.b. va Stayfree; hamda ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson’s Baby, Johnson’s Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed va Visine/Vispring/Visclear brendlari ostida sotadi. Kenvue Inc. 2022-yilda ro'yxatdan o'tgan va shtab-kvartirasi Nyu-Jersi shtatining Summit shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Caroline Tillett Ph.D. | Chief Scientific Officer |
| Mr. Amit Banati | Chief Financial Officer |
| Mr. Carlton Lawson | Group President of Europe, Middle East & Africa |
| Mr. Jonathan Halvorson | Chief Digital & Marketing Officer |
| Mr. Kirk L. Perry | CEO & Director |
| Mr. Matthew Orlando | General Counsel |
| Mr. Michael P. Wondrasch | Chief Technology & Data Officer |
| Ms. Heather R. Howlett | Chief Accounting Officer |
| Ms. Meredith Stevens | Chief Operations Officer |
| Ms. Sofya Tsinis | Head of Investor Relations |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-07 | 8-K | kvue-20260507.htm |
| 2026-05-07 | 10-Q | kvue-20260329.htm |
| 2026-04-15 | 8-K | form8-k.htm |
| 2026-04-08 | DEF 14A | kvue-20260408.htm |
| 2026-02-20 | 10-K | kvue-20251228.htm |
| 2026-02-17 | 8-K | kvue-20260217.htm |
| 2026-02-12 | 8-K | form8-k.htm |
| 2026-01-29 | 8-K | kvue-20260129.htm |
| 2026-01-16 | 8-K | ef20063257_8k.htm |
| 2026-01-13 | 425 | tm263109d1_425.htm |